from Reuters: Science News https://ift.tt/2PK6nWN
//
AstraZeneca's Lynparza shown to put brakes on ovarian cancer
October 23, 2018 / / in Reuters: Science News / with No comments /
An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S. rivals in the same class.
from Reuters: Science News https://ift.tt/2PK6nWN
//
from Reuters: Science News https://ift.tt/2PK6nWN
//
Related Posts:
Brazilian physicist wins $1.4 million Templeton Prize- Boeing delays by months test flights for U.S. human space program: sources
- Russian space rocket lifts off with astronauts who survived rocket failure
- WHO panel calls for registry of all human gene editing research
- China clones 'Sherlock Holmes' police dog to cut training times: state media
0 comments:
Post a Comment